2021 |
Sex disparity in subsequent outcomes in survivors of coronary heart disease
10.1136/heartjnl-2021-319566
Authors: R. Akyea, E. Kontopantelis, J. Kai, S. Weng, R. Patel, F. Asselbergs, N. Qureshi |
2008 |
Sex- and age-specific incidence of fractures in mental illness: a historical, population-based cohort study
Authors: K. Abel, H. Heatlie, L. Howard, R. Webb |
2021 |
Sex, Age, and Socioeconomic Differences in Nonfatal Stroke Incidence and Subsequent Major Adverse Outcomes
10.1161/strokeaha.120.031659
Authors: R. Akyea, Y. Vinogradova, N. Qureshi, R. Patel, E. Kontopantelis, G. Ntaios, F. Asselbergs, J. Kai, S. Weng |
2018 |
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
10.1016/j.jacc.2018.01.085
Authors: M. Cavender, A. Norhammar, K. Birkeland, M. Jorgensen, J. Wilding, K. Khunti, A. Fu, J. Bodegard, B. Blak, E. Wittbrodt, M. Thuresson, P. Fenici, N. Hammar, M. Kosiborod |
2021 |
SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study
10.1002/pds.5192
Authors: V. Brunetti, P. Reynier, L. Azoulay, O. H. Y. Yu, P. Ernst, R. Platt, K. Filion |
2023 |
SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study
10.1111/bcp.15787
Authors: S. Aloe, C. Filliter, S. Salmasi, S. Igweokpala, O. H. Y. Yu, V. Tagalakis, K. Filion |
2018 |
Short- and long-term cost and utilization of health care resources in Parkinson\textquoterights disease in the UK
10.1002/mds.27302
Authors: S. Weir, M. Samnaliev, T. Kuo, T. Tierney, Walleser Autiero, R. Taylor, A. Schrag |
2023 |
Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior
10.1183/23120541.00571-2022
Authors: A. Morgan, E. Maslova, C. Kallis, I. Sinha, G. Roberts, T. Tran, R. van der Valk, J. Quint |
2021 |
Shorter and longer courses of antibiotics for common infections and the association with reductions of infection-related complications including hospital admissions
10.1093/cid/ciab159
Authors: V. Palin, W. Welfare, D. Ashcroft, T. van Staa |
1999 |
Should the corticosteroid to bronchodilator ratio be promoted as a quality prescribing marker?
10.1038/sj.ph.1900583
Authors: M. Frischer, H. Heatlie, S. Chapman, J. Norwood, J. Bashford, D. Millson |
2001 |
Siblings, multiple births, and the incidence of allergic disease: a birth cohort study using the West Midlands general practice research database
Authors: T. McKeever, S. Lewis, C. Smith, J. Collins, H. Heatlie, M. Frischer, R. Hubbard |
2022 |
Significant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting
10.1111/dom.14799
Authors: I. Idris, R. Zhang, J. Mamza, M. Ford, T. Morris, A. Banerjee, K. Khunti |
2020 |
Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5~years after diagnosis
10.1007/s10067-020-05237-7
Authors: C. Prieto, F. Ibrahim, R. Campbell, H. Chinoy, J. Galloway, P. Gordon |
2006 |
Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible
10.1016/j.jclinepi.2005.08.008
Authors: R. Tannen, M. Weiner, S. Marcus |
2022 |
Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
10.2147/copd.s378486
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
2013 |
SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink
10.1038/clpt.2013.161
Authors: D. Carr, H. O\textquoterightMeara, A. Jorgensen, J. Campbell, M. Hobbs, G. McCann, T. Van Staa, M. Pirmohamed |
2017 |
Sleep disturbance and the older worker: findings from the Health and Employment after Fifty study
10.5271/sjweh.3618
Authors: K. Palmer, S. D\textquoterightAngelo, E. Harris, C. Linaker, A. Sayer, C. Gale, M. Evandrou, T. Van Staa, C. Cooper, D. Coggon |
2017 |
SMAD3/Stat3 Signaling Mediates beta-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes
10.2337/db17-0537
Authors: X. Xiao, S. Fischbach, T. Zhang, C. Chen, Q. Sheng, R. Zimmerman, S. Patnaik, J. Fusco, Y. Ming, P. Guo, C. Shiota, K. Prasadan, N. Gangopadhyay, S. Husain, H. Dong, G. Gittes |
2015 |
Smoke-free legislation and the incidence of paediatric respiratory infections and wheezing/asthma: interrupted time series analyses in the four UK nations
10.1038/srep15246
Authors: J. Been, L. Szatkowski, T. van Staa, H. Leufkens, O. van Schayck, A. Sheikh, F. de Vries, P. Souverein |
2014 |
Smoking cessation interventions following acute coronary syndrome: a missed opportunity?
10.1177/2047487312460517
Authors: R. Boggon, A. Timmis, H. Hemingway, S. Raju, F. Malvestiti, T. van Staa |
2013 |
Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study
10.1136/bmj.f5704
Authors: K. Thomas, R. Martin, N. Davies, C. Metcalfe, F. Windmeijer, D. Gunnell |
2024 |
Smoking is a Risk Factor for Autoimmune Hepatitis: An English Registry-Based Case-Control Study
10.2147/clep.s439219
Authors: L. Grønbæk, H. Omeife, L. Ban, C. Crooks, T. Card, P. Jepsen, J. West |
2018 |
Smoking Status at Diagnosis and Subsequent Smoking Cessation: Associations With Corticosteroid Use and Intestinal Resection in Crohn\textquoterights Disease
10.1038/s41395-018-0273-7
Authors: C. Alexakis, S. Saxena, V. Chhaya, E. Cecil, A. Majeed, R. Pollok |
2016 |
Smoking-Related Mortality in Patients With Early Rheumatoid Arthritis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink
10.1002/acr.22882
Authors: R. Joseph, M. Movahedi, W. Dixon, D. Symmons |
2021 |
Social and ethnic group differences in healthcare use by children aged 0-14 years: a population-based cohort study in England from 2007 to 2017
10.1136/archdischild-2020-321045
Authors: C. Coughlan, J. Ruzangi, F. Neale, Nezafat Maldonado, M. Blair, A. Bottle, S. Saxena, D. Hargreaves |
2014 |
Social and material deprivation and the cost-effectiveness of an intervention to promote physical activity: cohort study and Markov model
10.1093/pubmed/fdt132
Authors: M. Gulliford, J. Charlton, N. Bhattarai, C. Rudisill |
2022 |
Social and spatial inequalities in healthcare use among people living with dementia in England (2002-2016)
10.1080/13607863.2022.2107176
Authors: J. Watson, M. Green, C. Giebel, F. Darlington-Pollock, A. Akpan |
2021 |
Social determinants of pertussis and influenza vaccine uptake in pregnancy: a national cohort study in England using electronic health records
10.1136/bmjopen-2020-046545
Authors: J. Walker, C. Rentsch, H. McDonald, J. Bak, C. Minassian, G. Amirthalingam, M. Edelstein, S. Thomas |
2019 |
Socio-economic inequalities in life expectancy of older adults with and without multimorbidity: a record linkage study of 1.1 million people in England
10.1093/ije/dyz052
Authors: M. Chan, A. van den Hout, M. Pujades-Rodriguez, M. Jones, F. Matthews, C. Jagger, R. Raine, M. Bajekal |
2013 |
Socio-economic position and childhood multimorbidity: a study using linkage between the Avon Longitudinal Study of Parents and Children and the General Practice Research Database
10.1186/1475-9276-12-66
Authors: R. Cornish, A. Boyd, T. Van Staa, C. Salisbury, J. Macleod |
2019 |
Socioeconomic deprivation and regional variation in Hodgkin\textquoterights lymphoma incidence in the UK: a population-based cohort study of 10 million individuals
10.1136/bmjopen-2019-029228
Authors: M. Rafiq, A. Hayward, C. Warren-Gash, S. Denaxas, A. Gonzalez-Izquierdo, G. Lyratzopoulos, S. Thomas |
2019 |
Socioeconomic disadvantage and the risk of advanced chronic kidney disease: results from a cohort study with 1.4 million participants
10.1093/ndt/gfz059
Authors: M. Weldegiorgis, M. Smith, W. Herrington, C. Bankhead, M. Woodward |
2023 |
Socioeconomic gradient in mortality of working age and older adults with multiple long-term conditions in England and Ontario, Canada
10.1186/s12889-023-15370-y
Authors: A. Alarilla, L. Mondor, H. Knight, J. Hughes, A. Koné, W. Wodchis, M. Stafford |
2024 |
Socioeconomic inequalities in accumulation of multimorbidity in England from 2019 to 2049: a microsimulation projection study
10.1016/s2468-2667(24)00028-8
Authors: A. Head, M. Birkett, K. Fleming, C. Kypridemos, M. O'Flaherty |
2016 |
Sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care database
10.1136/bmjopen-2016-011661
Authors: C. Fairhurst, F. Martin, I. Watt, T. Doran, M. Bland, W. Brackenbury |
2023 |
Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data
10.1136/bmjopen-2022-064376
Authors: C. Fairhurst, F. Martin, I. Watt, M. Bland, T. Doran, W. Brackenbury |
2019 |
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
10.2337/dc19-0849
Authors: D. Abrahami, A. Douros, H. Yin, O. H. Y. Yu, L. Azoulay |
2022 |
Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study
10.2337/dc22-1174
Authors: D. Abrahami, H. Tesfaye, H. Yin, S. Vine, B. Hicks, O. H. Y. Yu, L. Campeau, R. Platt, S. Schneeweiss, E. Patorno, L. Azoulay |
2020 |
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study
10.7326/m20-0289
Authors: A. Douros, L. Lix, M. Fralick, S. Dell'Aniello, B. Shah, P. Ronksley, É Tremblay, N. Hu, S. Alessi-Severini, A. Fisher, S. Bugden, P. Ernst, K. Filion |
2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
10.1093/ehjcvp/pvae022
Authors: T. Eroglu, R. Coronel, P. Souverein |
2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
10.1111/bcp.16039
Authors: S. Shapiro, H. Yin, O. H. Y. Yu, L. Azoulay |
2021 |
Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study
10.1016/j.jcjd.2021.12.005
Authors: W. Alkabbani, A. Zongo, J. Minhas-Sandhu, D. Eurich, B. Shah, M. Alsabbagh, J. Gamble |
2018 |
Spatial distribution of clinical computer systems in primary care in England in 2016 and implications for primary care electronic medical record databases: a cross-sectional population study
10.1136/bmjopen-2017-020738
Authors: E. Kontopantelis, R. Stevens, P. Helms, D. Edwards, T. Doran, D. Ashcroft |
1995 |
Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices\textquoteright prescribing in England
Authors: D. Lloyd, C. Harris, D. Roberts |
2012 |
Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study
10.1136/bmj.e4447
Authors: I. Mackenzie, T. MacDonald, A. Thompson, S. Morant, L. Wei |
2017 |
Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
10.1111/bcp.13152
Authors: I. Mackenzie, S. Morant, L. Wei, A. Thompson, T. MacDonald |
2017 |
Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research Datalink
10.1080/15412555.2017.1313827
Authors: S. Landis, R. Suruki, E. Hilton, C. Compton, N. Galwey |
2017 |
Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts
10.1164/rccm.201701-0009LE
Authors: O. Oshagbemi, A. Burden, D. Braeken, Y. Henskens, E. Wouters, J. Driessen, A. van der Zee, F. de Vries, F. Franssen |
2024 |
Standardizing to Specific Target Populations in Distributed Networks and Multi-Site Pharmacoepidemiologic Studies
10.1093/aje/kwae015
Authors: M. Webster-Clark, K. Filion, R. Platt |
2008 |
Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006
10.1371/journal.pone.0002522
Authors: M. Molokhia, P. McKeigue, V. Curcin, A. Majeed |